%0 Journal Article
%T 利奈唑胺致新生儿血小板减少1例并文献复习<br>A Case Report of Linezolid-Induced Thrombocytopenia in a Neonate and Literature Review
%A 张晓宁
%J Advances in Clinical Medicine
%P 111-116
%@ 2161-8720
%D 2025
%I Hans Publishing
%R 10.12677/acm.2025.1551348
%X 利奈唑胺通常用于治疗新生儿多重耐药革兰氏阳性菌感染。新生儿属特殊用药群体&#65292;其器官功能尚未发育成熟&#65292;利奈唑胺的药品不良反应发生率&#65292;尤其是利奈唑胺所致血小板减少的风险值得重视。新生儿使用利奈唑胺后的不良反应主要表现为血小板减少、血红蛋白降低及粒细胞减少等血液系统毒性反应&#65292;停药后可恢复正常。本文介绍1例重症感染后应用利奈唑胺致重度血小板减少患者的临床资料&#65292;以提高临床医师对利奈唑胺致新生儿不良反应规范化诊疗的认知。<br>Linezolid is commonly used for the treatment of multi-drug resistant Gram-positive bacterial infections in neonates. Neonates are a special group of drug users whose organ functions are not yet mature, and the incidence of adverse drug reactions to linezolid, especially the risk of thrombocytopenia caused by linezolid, is worthy of attention. Adverse reactions in neonates after using linezolid are mainly manifested as thrombocytopenia, hemoglobin reduction granulocytopenia and other hematologic toxic reactions, which can be restored to normal after stopping the drug. In this article, we present the clinical data of a patient with severe thrombocytopenia caused by the application of linezolid after severe infection to improve the clinicians&#8217; knowledge of standardized diagnosis and treatment of linezolid-induced adverse reactions in neonates.
%K 利奈唑胺&#65292
%K 新生儿&#65292
%K 血小板减少&#65292
%K 不良反应<br>Linezolid
%K Neonates
%K Thrombocytopenia
%K Adverse Effects
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=113661